Hemgenix continues to be specified ‘conditional authorisation’. Consequently the ecu Medicines Agency decided that the benefits of Hemgenix are larger than its risks, but the organization must provide extra proof immediately after authorisation.Hemgenix is a medicine used to treat Older people with critical and reasonably serious haemophilia B,